Company: SINT
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010496
Chunk: 39

Company: Sintx Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 2
Chunk 39
---
You should read the following discussion and analysis
of our financial condition and results of operations in conjunction with our consolidated financial statements for the year ended December
31, 2024 and the notes thereto, along with Management’s Discussion and Analysis of Financial Condition and Results of Operations,
included in our Annual Report on Form 10-K for the year ended December 31, 2024, filed separately with the U.S. Securities and Exchange
Commission. This discussion and analysis contains forward-looking statements based upon current beliefs, plans, expectations, intentions
and projections that involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, expectations, intentions
and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking
statements as a result of several factors, including those set forth under the “Risk Factors” section of our Annual Report
on Form 10-K for the year ended December 31, 2024, and any updates to those risk factors filed from time to time in our Quarterly Reports
on Form 10-Q and in other filings with the Securities and Exchange Commission we may make from time-to-time.

Overview

SINTX
Technologies is an advanced ceramics company formed in December 1996, focused on providing biomedical solutions for medical devices.
We have grown from focusing primarily on the research, development and commercialization of medical devices manufactured with silicon
nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical and antipathogenic applications. This
diversification enables us to focus on our core competencies which are the manufacturing, research, and development of products comprised
from advanced ceramic materials. We seek to connect with new customers, partners and manufacturers to help them realize the goal of leveraging
our expertise in advanced ceramics to create new, innovative products across these sectors.

SINTX
Core Business

Biomedical
Applications: Since its inception, SINTX has been focused on medical grade silicon nitride. SINTX biomedical products have been shown
to be biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have
been successfully implanted in humans since 2008 in the U.S., Europe, South America and Asia. This established use, along with its inherent
resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as
arthroplasty implants, foot wedges,